title: Lipid apheresis: an in vivo application of plasma delipidation with organic solvents resulting in acute transient reduction of circulating plasma lipids in animals.
abstract: Despite primary and secondary prevention of coronary disease with lowering plasma cholesterol by diet and drug therapy, coronary heart disease remains the major cause of death in Western countries. Low density lipoprotein apheresis had the potential to make a significant impact as it acutely leads to a marked reduction in plasma cholesterol. However, recent preliminary results suggest that low density lipoprotein apheresis may not be more effective in preventing progression of coronary disease than current drug therapy. We have devised a new technique, termed lipid apheresis, which removes cholesterol and triglycerides from plasma but retains the apolipoproteins. This procedure shows great promise in stimulating regression beyond current therapy. Lipid apheresis, a new extracorporeal procedure based on plasma delipidation with the organic solvent mixture butanol-diisopropyl ether, was applied to hypercholesterolemic and normocholesterolemic roosters. Approximately 25% of the calculated blood volume was removed from the animals. The plasma was separated from the blood cells. The plasma was delipidated for 20 min with the organic solvent mixture. The delipidated plasma containing all proteins, including the apolipoproteins and other ionic constituents, was remixed with the blood cells and infused back into the identical donor animals. Analyses of serial blood samples collected from lipid apheresed and sham treated animals up to 16 h after infusion revealed that lipid apheresis caused acute, marked reductions in plasma lipids. The pattern and extent of the plasma levels of cholesterol were different in the hypercholesterolemic animals when compared with normocholesterolemic animals, indicating that a readily extraplasma cholesterol pool in the hypercholesterolemic animals was rapidly mobilized into the plasma pool.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, University of Queensland, Royal Brisbane Hospital, Herston, Australia.
authors.forename: B E
authors.initials: BE
authors.lastname: Cham
authors.forename: K M
authors.initials: KM
authors.lastname: Kostner
authors.forename: A K
authors.initials: AK
authors.lastname: Dwivedy
authors.forename: T M
authors.initials: TM
authors.lastname: Shafey
authors.forename: N X
authors.initials: NX
authors.lastname: Fang
authors.forename: M G
authors.initials: MG
authors.lastname: Mahon
authors.forename: C I
authors.initials: CI
authors.lastname: Iannuzzi
authors.forename: D M
authors.initials: DM
authors.lastname: Colquhoun
authors.forename: J L
authors.initials: JL
authors.lastname: Smith
mesh_terms: D000818:Animals; D001781:Blood Component Removal; D002645:Chickens; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D006937:Hypercholesterolemia / Q000628:therapy*; D008055:Lipids / Q000097:blood*; D008297:Male; D012997:Solvents / Q000627:therapeutic use*
chemical_list: D002791:Cholesterol, Dietary; D008055:Lipids; D012997:Solvents